// App-Quantinova.ai

: Olverembatinib Based Therapy in Recurrent Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR/ABL Mutation

Researchers

Presenter

  • Qiuxia Lv

Principal Investigators

  • Qiuxia Yu

  • Yang Cao

  • Jue Wang

  • Yicheng Zhang

  • Gaoxiang Wang

  • Zhenya Hong

  • Li Meng

Medical Centers

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., wuhan, China

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  • Tongji Hospital, Tongji Medical College, Lianyungang, CHN

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

Drug/Treatment

  • Glucocorticoid

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved